← Leaderboards
George Daniel Maynard
Renetx Bio, Inc.
$358,967
Attributed
$626,912
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $426K · FY2013–15$500K$375K$250K$125K$0
'13
'14
'15
Funding mix
By agency
NIH$626,912 · 2
By mechanism
U01$401,917 · 1
R41$224,995 · 1
Top collaborators
- Erik C Gunther3 shared
- Stephen M Strittmatter3 shared
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposAntibodiesBlood - Brain Barrier AnatomyAbsorptionBaseAnti-Prp AntibodiesApp-Ps1AssesAnalogAgedCognitive FunctionBinding (Molecular Function)Binding SitesBiologicalAmyloid Beta-ProteinBrainCare BurdenCell DeathCellsCell SurfaceCessation Of LifeClinical TrialsCollaborationsComplex
Grant awards (4)
Small Molecule Development of PrPc Antagonists for the Treatment of Alzheimer's D$1
U01 · FY2015 · AG · contact PI
Small Molecule Development of PrPc Antagonists for the Treatment of Alzheimer's D$200,958
U01 · FY2014 · AG · contact PI
Nogo Decoy Receptor Therapy for the Treatment of Glaucoma$224,995
R41 · FY2013 · MD · contact PI
Small Molecule Development of PrPc Antagonists for the Treatment of Alzheimer's D$200,958
U01 · FY2013 · AG · contact PI